Mpox vaccine upgrade: new manufacturing method tested in 970 adults
NCT ID NCT07199569
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 31 times
Summary
This study tests whether the MVA-BN mpox vaccine works just as well when made in a different type of cell. About 970 healthy adults aged 18 to 49 will receive two doses. Researchers will compare immune responses and side effects between the standard and new production methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONKEYPOX (MPOX) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accellacare - Knoxville
Knoxville, Tennessee, 37938, United States
-
Accellacare Research of Salisbury
Salisbury, North Carolina, 28144, United States
-
Accellacare and McFarland Clinic
Ames, Iowa, 50010, United States
-
Accellacare of Cary - Cary Medical Group
Cary, North Carolina, 27518, United States
-
Accellacare of Charleston
Mt. Pleasant, South Carolina, 29464, United States
-
Avacare
Austin, Texas, 78705, United States
-
Avacare
Fort Worth, Texas, 76135, United States
-
Johnson County ClinTrials, LLC
Lenexa, Kansas, 66219, United States
-
Rochester Clinical Research, Inc
Rochester, New York, 14609, United States
-
Velocity Clinical Research
Suffolk, Virginia, 23435, United States
Conditions
Explore the condition pages connected to this study.